Product Information

BIMATOPROST 0.03% EYE DROPS is a generic product labeled by Aurobindo Pharma Limited, priced at $6.5311 per ML under NDC 65862080205. Its NADAC has been published 163 times since Oct 11, 2023.

FDA first approved this application on Oct 6, 2022. Its Orange Book therapeutic-equivalence code is AT.

BIMATOPROST 0.03% EYE DROPS

Bimatoprost
$6.5311per ML

Strength

.3 mg/mL

NDC

65862080205

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

BIMATOPROST

Approval Type

Generic (ANDA)

FDA Application

ANDA205537

FDA Approved

10/6/2022

TE Code

AT

On Market Since

10/6/2022

Pharmacological Classes

Prostaglandin Analog
Prostaglandins

Price Statistics

The NADAC for BIMATOPROST 0.03% EYE DROPS has been published 163 times since Oct 11, 2023, and over the history we have for it it has declined 69.9%. The table below summarizes its recorded NADAC range and movement.

Current price$6.5311 per ML
All-time high$21.7020 (Oct 11, 2023)
All-time low$6.5311 (Nov 18, 2026)
52-week high$11.1579
52-week low$6.5311
Median price$12.6397
Average price$12.9695
Largest weekly change+33.5% (Sep 18, 2024)
Weeks tracked163
Tracking sinceOct 11, 2023

Price History

1W

-15.7%

1M

-26.2%

3M

-26.4%

6M

-7.1%

1Y

-41.5%

3Y

-69.6%

5Y

N/A

All

-69.9%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BIMATOPROST 0.03% EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for BIMATOPROST 0.03% EYE DROPS, manufactured by Aurobindo Pharma Limited, is $6.5311 per ML (NDC 65862080205), effective Nov 18, 2026.

How has the price of BIMATOPROST 0.03% EYE DROPS changed over time?

Over the history we have for it, the NADAC for BIMATOPROST 0.03% EYE DROPS has declined 69.9%. It has been tracked across 163 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for BIMATOPROST 0.03% EYE DROPS?

Since Oct 11, 2023, the NADAC for BIMATOPROST 0.03% EYE DROPS has ranged from a low of $6.5311 (Nov 18, 2026) to a high of $21.7020 (Oct 11, 2023), with a median of $12.6397 per ML.

Are there cheaper alternatives to BIMATOPROST 0.03% EYE DROPS?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BIMATOPROST 0.03% EYE DROPS, is $3.7093 per ML — about 43% below BIMATOPROST 0.03% EYE DROPS.

Who manufactures BIMATOPROST 0.03% EYE DROPS?

BIMATOPROST 0.03% EYE DROPS (NDC 65862080205) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.